Meta-analysis of effect of vernakalant on conversion of atrial fibrillation

BACKGROUND: In recent years, there has been a large amount of studies about the efficacy and safety of vernakalant or RSD1235, an antiarrhythmic agent, in treating the atrial fibrillation (AF). This study was designed to assess the efficacy and safety of vernakalant in the treatment of AF. RESULTS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, He, Aung, Thi Thi, Guoqiang, Zhong, Zhengnan, Zhang, Lan, Ji, Zhiyu, Zeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3610119/
https://www.ncbi.nlm.nih.gov/pubmed/23497611
http://dx.doi.org/10.1186/1756-0500-6-94

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3610119/
https://www.ncbi.nlm.nih.gov/pubmed/23497611
http://dx.doi.org/10.1186/1756-0500-6-94

Ejemplares similares